Cite
HARVARD Citation
Tiu, C. et al. (2021). Preliminary evidence of antitumour activity of Ipatasertib (Ipat) and Atezolizumab (ATZ) in glioblastoma patients (pts) with PTEN loss from the Phase 1 Ice-CAP trial (NCT03673787). Neuro-oncology. p. iv10. [Online].